AN OVERVIEW OF ECONOMIC ANALYSIS FOR NEW TECHNOLOGIES
A thorough economic analysis should be used to guide the clinical research protocol to ensure that the end points measured are commercially relevant and useful. The analysis should describe important ele-ments of the market to the firm, helping decision makers to understand the way decisions are made and providing guidance in affecting those decisions. Later, the results of economic analyses should inform and guide marketing and pricing decisions as the product is prepared for launch, as well as help customers to use the product efficiently and effectively.
money through the various health care systems. This process should begin as soon as the likely indications for a new product have been identified and continue throughout the product’s development. The first step is to create basic economic models of the current treatment for the disorder(s) for which the product is likely to be indicated. This step will be used to provide better information to fine-tune financial assumptions and to provide critical input into the clinical development process to assure that the clinical protocols are designed to extract the greatest com-mercial potential from the product. If the product is likely to be used for more than one indication and/or if there is the potential that several different levels of the same indication (e.g., mild, moderate, and severe) would be treated by the same product, separate models should be prepared for each indication and level.
The purpose of the basic model is to provide a greater understanding of the costs associated with the disorder and to identify areas and types of cost that provide the greatest potential for the product to generate cost savings. For example, the cost of a disorder that currently requires a significant amount of laboratory testing offers the potential for savings, and thus better pricing, if the new product can reduce or eliminate the need for tests. Similarly, some indications are well treated, but the incidence of side effects is sufficiently high to warrant special attention. When developing a new agent, it is as important to understand the source of the value to be provided as it is to understand the clinical effects of the agent.
Copyright © 2018-2020 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.